Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Polyethylene Glycols »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Polyendocrinopathies, Autoimmune < Polyethylene Glycols < Polymerase Chain Reaction  Facettes :

List of bibliographic references indexed by Polyethylene Glycols

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
001E31 (2015) Dorota Suszek ; Arkadiusz Koszarny ; Radosław Jeleniewicz ; Maria Majdan ; Anna Bo Czak ; Agnieszka Czukiewska ; Barbara Koszła ; Sylwia Kurlej ; Justyna Markowicz ; Agnieszka Szymczyk[Biological treatment in severe Still's disease--a case report].
002011 (2015) Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
002139 (2015) E M Dijkgraaf [Pays-Bas] ; S J A M. Santegoets [Pays-Bas] ; A K L. Reyners ; R. Goedemans [Pays-Bas] ; M C A. Wouters [Pays-Bas] ; G G Kenter [Pays-Bas] ; A R Van Erkel ; M I E. Van Poelgeest [Pays-Bas] ; H W Nijman ; J J M. Van Der Hoeven [Pays-Bas] ; M J P. Welters [Pays-Bas] ; S H Van Der Burg [Pays-Bas] ; J R Kroep [Pays-Bas]A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
002287 (2014) Fabrizio Cantini [Italie] ; Laura Niccoli ; Delia GolettiTuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
002366 (2014) E. Bizzi [Oman] ; U. Massafra ; B. Laganà ; V. Bruzzese ; A Picchianti Diamanti ; M. Cassol ; A. MiglioreRadiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.
002476 (2014) Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika OgaleComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
002497 (2014) C. Gabay [Suisse] ; P. Hasler ; D. Kyburz ; A. So ; P. Villiger ; J. Von Kempis ; U. WalkerBiological agents in monotherapy for the treatment of rheumatoid arthritis.
002834 (2013) Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis]Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012
003408 (2012) Yutaka Kohgo ; Hiroki Tanabe ; Mikihiro Fujiya[Current status of new drug development for inflammatory bowel diseases].
003503 (2012) Jatinder P. Ahluwalia [États-Unis]Immunotherapy in inflammatory bowel disease.
003504 (2012) Anne V. Miller [États-Unis] ; Sriya K M. RanatungaImmunotherapies in rheumatologic disorders.
003857 (2011) Valentin Brodszky [Hongrie][Effectiveness of biological treatments based on ACR70 response in rheumatoid arthritis: indirect comparison and meta-regression using Bayes-model].
003910 (2011) Andreas V. Hadjinicolaou [Royaume-Uni] ; Muhammad K. Nisar ; Shweta Bhagat ; Helen Parfrey ; Edwin R. Chilvers ; Andrew J K. OstörNon-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.
003B94 (2011) Robert Launois [France] ; Bernard Avouac ; Francis Berenbaum ; Olivier Blin ; Isabelle Bru ; Bruno Fautrel ; Jean-Michel Joubert ; Jean Sibilia ; Bernard CombeComparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis
003E83 (2009) Kazuyoshi Saito ; Yoshiya Tanaka[New biologic and non biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Polyethylene Glycols" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Polyethylene Glycols" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Polyethylene Glycols
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021